These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA. J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981 [Abstract] [Full Text] [Related]
3. The value of diffusion-weighted MRI for prostate cancer detection and localization. Yağci AB, Ozari N, Aybek Z, Düzcan E. Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948 [Abstract] [Full Text] [Related]
9. Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map. Rosenkrantz AB, Kong X, Niver BE, Berkman DS, Melamed J, Babb JS, Taneja SS. AJR Am J Roentgenol; 2011 Jan; 196(1):123-9. PubMed ID: 21178056 [Abstract] [Full Text] [Related]
10. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. Lim HK, Kim JK, Kim KA, Cho KS. Radiology; 2009 Jan; 250(1):145-51. PubMed ID: 19017927 [Abstract] [Full Text] [Related]
12. Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study. Chong Y, Kim CK, Park SY, Park BK, Kwon GY, Park JJ. AJR Am J Roentgenol; 2014 Apr; 202(4):772-7. PubMed ID: 24660705 [Abstract] [Full Text] [Related]
13. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M. Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184 [Abstract] [Full Text] [Related]
15. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. Kim CK, Park BK, Lee HM. J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194 [Abstract] [Full Text] [Related]
17. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, deSouza NM. AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350 [Abstract] [Full Text] [Related]
18. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. Kim CK, Park BK, Kim B. AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888 [Abstract] [Full Text] [Related]
19. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. Kim CK, Park BK, Lee HM, Kim SS, Kim E. AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829 [Abstract] [Full Text] [Related]
20. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T. Rosenkrantz AB, Kim S, Campbell N, Gaing B, Deng FM, Taneja SS. AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311 [Abstract] [Full Text] [Related] Page: [Next] [New Search]